Solventum (SOLV) Expected to Announce Earnings on Thursday

Solventum (NYSE:SOLVGet Free Report) will likely be posting its quarterly earnings results after the market closes on Thursday, February 27th. Analysts expect Solventum to post earnings of $1.31 per share and revenue of $2.05 billion for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

Solventum Trading Down 0.5 %

SOLV stock opened at $73.97 on Thursday. Solventum has a twelve month low of $47.16 and a twelve month high of $96.05. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. The firm has a 50 day simple moving average of $70.98 and a 200-day simple moving average of $68.91.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. Morgan Stanley raised their price target on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research report on Monday, November 11th. Mizuho began coverage on shares of Solventum in a report on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price objective for the company. Finally, Piper Sandler lifted their price objective on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $68.29.

View Our Latest Stock Analysis on Solventum

Solventum Company Profile

(Get Free Report)

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

Read More

Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.